- 英文名称
- Carboxyatractyloside dipotassium salt
- 分子式
- C31H44K2O18S2
- 分子量
- 847
- 中文别名
- 胶苍术甙; 羟基苍术苷; 羧基苍术苷; 胶苍术苷; (2S,4aS,6aR,7S,9R,11aS,11bS)-7-羟基-2-(((2R,3R,4R,5R,6R)-6-(羟甲基)-3-((3-甲基丁酰基)氧基)-4,5-双(磺氧基)四氢-2H-吡喃-2-基)氧基)-11b-甲基-8-亚甲基十二氢-6a,9-甲桥环庚并[a]萘-4,4(4aH)-二羧酸二钾盐; 4-carboxyatractyloside dipotassium salt; Dipotassium dihydrogen 15α-hydroxy-2β-((2-O-isovaleryl-3,4-di-O-sulphonato-β-D-glucopyranosyl)oxy)kaur-16-ene-18,19-dioate; Hydrogen potassium (2β,15α)-15-hydroxy-2-{[2-O-(3-methylbutanoyl)-3,4-di-O-sulfonato-β-D-glucopyranosyl]oxy}kaur-16-ene-18,19-dioate (2:2:1); Carboxyatractyloside; Gummiferin; 4-CARBOXY-ATRACTYLOSIDE; 15α-Hydroxy-2β-[[2-O-(3-methyl-1-oxobutyl)-3-O,4-O-di-(potassiooxysulfonyl)-β-D-glucopyranosyl]oxy]kaur-16-ene-18,19-dioic acid; Dipotassium carboxyatractyloside; Potassium carboxyatractyloside; Carboxyatractyloside dipotassium; (2S,4aS,6aR,7S,9R,11aS,11bS)-7-Hydroxy-2-(((2R,3R,4R,5R,6R)-6-(hydroxymethyl)-3-((3-methylbutanoyl)oxy)-4,5-bis(sulfooxy)tetrahydro-2H-pyran-2-yl)oxy)-11b-methyl-8-methylenedodecahydro-6a,9-methanocyclohepta[a]naphthalene-4,4(4aH)-dicarboxylic acid dipotassium salt
- 用途
- 作为ADP/ATP载体蛋白抑制剂,抑制线粒体ADP/ATP转运;用于生命科学研究;中草药成分